Open Now: The Global ETF Survey Take the Survey →
Corgi Genomics & Precision Medicine ETF
GNMX performance and flow charts
Performance
Flows
Historic performance and flows
Data as of July 24, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +1.85% | |||||
| Flows | - | - | - | - | - | - |
Characteristics
This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
| Management strategy | Active |
| Strategy | Long Only |
| Provider | Corgi Funds |
| N° of holdings | 57 |
| Dividend policy | Distributing |
| Inception date | May 6, 2026 |
| ESG | No |
More data and info about GNMX on Trackinsight
Exposure
Data as of June 30, 2026Diversification
Total weight of top 15 holdings out of 57
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | ||||
Max drawdown | ||||
Max drawdown duration | N/A | N/A | N/A | N/A |
Time to recover | N/A | N/A | N/A | N/A |
What type of ETF is GNMX?
GNMX is a Active ETF that provides exposure to Equity assets. It is managed by Corgi Funds.
What does GNMX invest in?
This ETF provides exposure to Other Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of GNMX?
The total expense ratio (TER) of GNMX is 0.35%, representing the annual fee charged by the fund manager.
When was GNMX launched?
GNMX was launched on May 6, 2026, marking its entry into the ETF market.
Who is the issuer of GNMX?
GNMX is issued by Corgi Funds.
What is the AUM of GNMX?
As of July 24, 2026, GNMX manages $1.64 M, reflecting the total assets held in the fund.
How many holdings are in GNMX
As of June 30, 2026, GNMX holds 57 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is GNMX?
As of June 30, 2026, GNMX holds 57 securities, with 53.1% of its assets concentrated in its top 15 holdings.
What are the top holdings of GNMX?
As of June 30, 2026, GNMX holds a portfolio of 57 underlyings, with its largest positions including Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does GNMX invest in?
As of June 30, 2026, GNMX has its largest geographic exposures in USA.
What sectors or themes does GNMX focus on?
As of June 30, 2026, GNMX is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs July 20, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs July 13, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
First Look ETF
First Look ETF: Cash Deployment, Bond, and Hedged ETFs
In this season 6 episode of First Look ETF, Stephanie Stanton examines the latest ETF marketplace trends with NYSE and guests.
ETF Trends
ETF Industry KPIs July 6, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
Browse all educational columns
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.
